| 糖尿病视网膜病变药物治疗的研究进展 |
| |
| 引用本文： | 蒲一民,杨君,杨田. 糖尿病视网膜病变药物治疗的研究进展[J]. 国际眼科杂志, 2011, 11(12): 2134-2137. DOI: 10.3969/j.issn.1672-5123.2011.12.024 |
| |
| 作者姓名： | 蒲一民 杨君 杨田 |
| |
| 作者单位： | 中国四川省乐山市人民医院眼科,614000 |
| |
| 摘 要： | 糖尿病视网膜病变(diabetic retinopathy,DR)是糖尿病患者常见和严重的并发症之一,是糖尿病患者视力损害的最主要原因。随着对糖尿病发病机制的深入研究,近年来多种药物用于DR的防治并取得了一定疗效,包括糖皮质激素、血管生长因子抑制剂、蛋白激酶C(protein kinase C,PKC)抑制剂、肾素-血管紧张素受体拮抗剂坎地沙坦及非诺贝特等,我们就近年来药物治疗DR的现状及进展作一综述。
|
| 关 键 词： | 糖尿病 糖尿病视网膜病变 药物治疗 |
| 收稿时间： | 2011-08-15 |
Recent advances of the study on pharmacotherapies for diabetic retinopathy |
| |
| Yi-Min Pu,Jun Yang and Tian Yang. Recent advances of the study on pharmacotherapies for diabetic retinopathy[J]. International Eye Science, 2011, 11(12): 2134-2137. DOI: 10.3969/j.issn.1672-5123.2011.12.024 |
| |
| Authors: | Yi-Min Pu Jun Yang Tian Yang |
| |
| Affiliation: | Department of Ophthalmology,People’s Hospital of Leshan,Leshan 614000,Sichuan Province,China |
| |
| Abstract: | Diabetic retinopathy(DR)is one of the common and severe complications in patients with diabetes,which is the leading cause of impairment of vision in diabetic patients.In recent years,following advanced research of diabetic etiopathogenesis,further advances in pharmacotherapy have shown promise in the treatment of DR,including corticosteroids,vascular endothelial growth factor(VEGF) inhibitors,protein kinase C(PKC) inhibitors,renin-angiotensin system blockers Candesartan and fenofibrate.This review will focus on DR present and potential future pharmacologic treatments. |
| |
| Keywords: | diabetes diabetic retinopathy pharmaco-therapies |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《国际眼科杂志》浏览原始摘要信息 |
|
点击此处可从《国际眼科杂志》下载全文 |
|
